IBM International Business Machines Corporation

XNYS 253.70 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

IBM $253.70 —
Key stats
$253.70
52-Week Range
$199.19 – $332.46
YTD
-12.97%
IV Rank (30D)
15.22
Straddle Price
$19.93
P/C Vol Ratio
0.52
Market Cap
$239.6B
Open
$249.73
Day Range
$247.03 – $254.71
Volume
5,890,168
Prev Close
$252.11
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.12%
Beta vs SPY0.82
Cost of Equity (CAPM)9.20% (VRP-adj)
WACC8.44%
Volatility Risk Premium+30.5pp (IV − HV30)
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+5.1%
DCF Horizon12 years explicit + fade
Forward Tilt (NTM/TTM)×1.05 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$13.8B
Return on Equity (TTM)31.1%
Book / Price14.5%
Gross Margin (TTM)58.1%
FCF Margin (TTM)20.0%
Debt / Equity1.63
Quality Score4/6 — high quality (12y DCF)
Market-Implied Growth+5.4% (reverse-DCF on current price)
SMA 50$232.71 (Market Anchor value)
SMA 20 / Bollinger Mid$229.27
Bollinger Width / SMA207.2% (drives anchor stability)
Net Debt$49.0B
Market Cap$238B
Peers used for multiples: AAPL, AMD, AVGO, CSCO, GOOGL, META, MSFT, NVDA
60-Day Conviction
90%
20-Day Fair Value
≈ by Nov 23, 2026
$257.41
α +1.5% rank 33%
conviction
79%
40-Day Fair Value
≈ by Dec 22, 2026
$260.49
α +2.7% rank 32%
conviction
80%
60-Day Fair Value
≈ by Jan 20, 2027
$263.35
α +3.9% rank 39%
conviction
90%
MethodImplied PriceWeightDetail
DCF $246.91 16%
DDM (Gordon) $210.90 13%
Peer P/E $363.33 7% median 30.7× · 8 peers
Peer EV/EBITDA $443.35 7% median 25.3× · 8 peers
Peer P/B $409.44 1% median 11.2× · 8 peers
Peer P/S $872.68 5% median 11.3× · 8 peers
Market Anchor (SMA50) $232.71 33% stability 100% (BB-width)
Options Expected (B-L 30d) $252.21 16% 40 strikes · skew -0.19
As of 2026-10-23 · updated
About
Industry (SIC)
COMPUTER & OFFICE EQUIPMENT (3570) · industry map
Exchange
XNYS
Market Cap
$239.6B
Employees
287,000
List Date
1949-01-28
CIK
0000051143
Headquarters
Armonk, NY
Homepage
https://www.ibm.com

Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world. It provides software, IT consulting services, and hardware to help business customers modernize their technology workflows. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which includes 95% of all Fortune 500 companies. IBM's products, including Red Hat, watsonx, and mainframes, handle some of the world's most important data workloads in areas like finance and retail.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Month'21'22'23'24'25'26Avg
Jan-3.90%-1.82%-4.82%13.72%16.26%5.21%4.11%
Feb-1.34%-9.61%-4.29%-1.00%-3.18%-23.68%-7.18%
Mar10.37%7.14%2.26%1.47%-0.61%1.26%3.65%
Apr6.49%1.58%-4.28%-12.45%-3.40%-5.00%-2.84%
May-0.70%4.36%1.98%1.47%8.09%28.25%7.24%
Jun1.66%1.26%3.07%4.64%11.70%-12.24%1.68%
Jul-4.00%-7.32%7.86%9.73%-13.07%-22.30%-4.85%
Aug-0.76%-2.72%2.44%6.57%-2.62%3.34%1.04%
Sep-0.27%-8.37%-5.16%9.84%16.84%-4.96%1.32%
Oct-12.71%13.81%2.73%-5.76%7.30%12.38%*2.96%
Nov-3.00%7.74%9.05%9.20%1.26%--4.85%
Dec14.32%-5.54%1.87%-3.32%-3.09%--0.85%
Total3.46%-2.34%12.09%35.71%35.89%-25.44%9.89%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $230.67
SMA 50: $233.04
SMA 200: $250.46
Current: $253.56
EMA 12: $239.78
EMA 26: $235.01
MACD: 4.7651 | Signal: 3.4514
BULLISH
ADX (14): 20.10
WEAK TREND
+DI: 30.96
−DI: 10.84

Momentum Oscillators

RSI (14): 71.17
OVERBOUGHT
Stoch %K: 93.72
Stoch %D: 94.89
Williams %R: -7.12

Volume & Volatility

BB Upper: $252.27
BB Lower: $209.07
OVERBOUGHT
OBV: 163,144,042
Vol SMA 20: 5,986,883
Vol ROC: 74.37%
ATR: $7.52
True Range: $7.68
HV 20: 25.9%
HV 30: 29.9%
HV 60: 29.4%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-25T00:00:00 – 2026-10-23T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

Overall Assessment: NEUTRAL (Confidence Level: 7/10)

Key Drivers and Primary Risks:

  • Technical indicators suggest a range-bound market, with the stock trading near its middle Bollinger Band.
  • Recent news headlines are mixed, with positive sentiment from healthcare and AI-related stories, but negative sentiment from IBM's dividend yield discussion.
  • Risk metrics indicate moderate volatility, with a beta of 0.86 relative to SPY.

Investment Thesis: The stock appears to be consolidating in a range, with a potential breakout above the upper Bollinger Band or breakdown below the lower band. The recent news headlines suggest that the healthcare and AI sectors may continue to drive growth, but the negative sentiment around IBM's dividend yield could impact short-term performance.

Recent News Sentiment Impact: The positive news headlines from the healthcare and AI sectors have contributed to a slightly bullish sentiment, while the negative sentiment around IBM's dividend yield has tempered enthusiasm. Overall, the news sentiment is NEUTRAL.

Technical Analysis

Trend Direction:

  • Short-term (1-4 weeks): Consolidation in a range
  • Medium-term (1-3 months): Range-bound market with potential for breakout or breakdown
  • Long-term (3-12 months): Bullish trend, but currently consolidating

Support/Resistance Levels: The stock is trading near its middle Bollinger Band ($223.73), which serves as a key support level.

Momentum Signals:

  • RSI interpretation: Neutral (49.85)
  • MACD signal: Bearish
  • Bollinger Bands position: Squeeze, with the stock trading within the bands

Volume Analysis: The volume is relatively low, indicating a lack of institutional interest in the short term.

News & Sentiment Analysis

Recent Headlines Summary: The news headlines are mixed, with positive sentiment from healthcare and AI-related stories, but negative sentiment from IBM's dividend yield discussion.

Sentiment Assessment: NEUTRAL (positive and negative sentiments cancel each other out)

Catalyst Identification: Earnings announcements in the healthcare and AI sectors could drive growth, while a potential dividend increase or decrease could impact short-term performance.

Market Narrative: The market is range-bound, with the stock trading near its middle Bollinger Band. The recent news headlines suggest that the healthcare and AI sectors may continue to drive growth, but the negative sentiment around IBM's dividend yield has tempered enthusiasm.

Risk & Volatility Assessment

Beta Interpretation: Moderate risk relative to SPY (beta of 0.86)

Volatility Regime: Moderate volatility, with a stock volatility of 0.48

Options Market Signals:

  • IV Rank: Low
  • Put/Call Volume Ratio: Bearish sentiment

Downside Protection: The support level at $223.73 could provide some downside protection if the stock breaks below its current range.

Market Context & Positioning

Sector Performance: The healthcare and AI sectors are performing well, which could drive growth in the short term.

Institutional Activity: Institutional interest is low, indicating a lack of conviction in the short term.

Correlation Analysis: The stock has a moderate correlation with the market (R-squared interpretation).

Relative Valuation: The stock appears to be reasonably valued within its trading range.

Key Levels & Action Items

Critical Price Levels: Support at $223.73 and resistance at $245.08

Breakout/Breakdown Levels: A breakout above $245.08 or breakdown below $202.39 could trigger significant moves.

Time-Sensitive Catalysts: Earnings announcements in the healthcare and AI sectors could drive growth, while a potential dividend increase or decrease could impact short-term performance.

Risk Management: Stop-loss levels at $220.00 (5% below current price) and position sizing considerations based on volatility and market conditions.


Note: This analysis is based on the provided data and should not be taken as personalized investment advice.

Generated
Showing 1–10 of 50
Page 1 of 5
Earnings History
14 of 24 under expected move
Avg Expected Move
5.87%
Avg Actual Move
5.19%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-01-21 After-Close 6.12% 9.91% 1.62x Exceeded
2021-04-19 After-Close 6.39% 3.79% 0.59x Within
2021-07-19 After-Close 5.88% 1.49% 0.25x Within
2021-10-20 After-Close 5.35% 9.56% 1.79x Exceeded
2021-12-27 After-Close 1.50% 0.77% 0.51x Within
2022-04-19 After-Close 4.75% 7.10% 1.49x Exceeded
2022-07-18 After-Close 5.50% 5.25% 0.95x Within
2022-10-19 After-Close 5.71% 4.73% 0.83x Within
2023-01-25 After-Close 4.10% 4.48% 1.09x Exceeded
2023-04-19 After-Close 4.10% 0.03% 0.01x Within
2023-07-19 After-Close 4.08% 2.14% 0.52x Within
2023-10-25 After-Close 4.27% 4.87% 1.14x Exceeded
2024-01-24 After-Close 4.50% 9.49% 2.11x Exceeded
2024-04-24 After-Close 6.10% 8.25% 1.35x Exceeded
2024-07-24 After-Close 6.68% 4.33% 0.65x Within
2024-10-23 After-Close 6.31% 6.17% 0.98x Within
2025-01-29 After-Close 9.29% 12.96% 1.40x Exceeded
2025-04-23 After-Close 9.13% 6.58% 0.72x Within
2025-07-23 After-Close 6.37% 7.62% 1.20x Exceeded
2025-10-22 After-Close 6.67% 0.87% 0.13x Within
2026-01-28 After-Close 6.80% 5.13% 0.75x Within
2026-04-22 After-Close 6.85% 8.25% 1.20x Exceeded
2026-07-22 After-Close 6.88% 0.43% 0.06x Within
2026-10-21 After-Close 7.51% 0.26% 0.03x Within

Earnings calendar: this week’s reports with expected vs actual moves →

IBM Options Activity & IV Rank

IBM IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 34.7%
7-DTE IV: 36.3%
Expected Move: $19.93
7-DTE Move: $10.35
Days to Exp: 28 (2026-11-20)

Options Flow

Call Volume: 4,885
Put Volume: 2,558
P/C Volume: 0.524
BULLISH
Call OI: 47,852
Put OI: 27,452
P/C OI: 0.574
Total OI: 75,304

ATM Options Pricing

ATM Call: $10.28
ATM Put: $9.65
Call %: 4.1%
Put %: 3.8%

Chain Summary

Chain Volume: 86,657
Chain OI: 597,928
Last Updated: 10/23/2026
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
TYPICAL γ

Estimated net dealer gamma is at the 63rd percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
63%
vs own history
GEX tilt
+0.37
OI-weighted, today
Vanna tilt
+0.39
δ-sensitivity to IV
Charm tilt
-0.38
δ-decay vs time
Vanna tilt +0.39: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.38: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 284 ATM contracts, 173k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d 49%
+2.8 pts EXTREME
as of Oct 23 · ATM 35.7% / Wing 38.5%
30 DTE / 10d 28%
+1.6 pts EXTREME
as of Oct 23 · ATM 35.6% / Wing 37.2%

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)19.3LowOct 23
IV Rank (30 DTE)15.2LowOct 23
Straddle Price (30 DTE)$19.93Oct 23
Beta Analysis

Risk Metrics

Beta: 0.8909
Alpha: -10.89%
Correlation: 0.2318
R-Squared: 5.4%
Stock Volatility: 49.0%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
Notable investors who own IBM
4 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$212.9M
0.12%
#180 of 6285+106.2%13F
Rockefeller Capital Management Family office
Rockefeller family
$176.9M
0.27%
#76 of 4729+1.7%13F
Millennium Management Hedge fund
Izzy Englander
$130.5M
0.09%
#259 of 3716+255.1%13F
ICONIQ Capital Family office$471K
0.01%
#63 of 76new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

IBM Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 953,780,474 (as of 2026-09-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

3,719 filers717,068,918 shares$202.46B value75.18% of float
# Filer Shares Value % of Total % of Float Period
1 Vanguard Group Inc Custodian 97,216,131 $28.80B 14.22% 10.19% 2025-12-31
2 BlackRock, Inc. Custodian 76,763,481 $21.59B 10.66% 8.05% 2026-06-30
3 Vanguard Capital Management LLC 61,385,366 $17.26B 8.53% 6.44% 2026-06-30
4 State Street Corp 56,045,055 $15.76B 7.78% 5.88% 2026-06-30
5 Vanguard Portfolio Management LLC 28,348,295 $7.97B 3.94% 2.97% 2026-06-30
6 Geode Capital Management, LLC Custodian 23,448,500 $6.58B 3.25% 2.46% 2026-06-30
7 Morgan Stanley Custodian 17,459,828 $4.91B 2.43% 1.83% 2026-06-30
8 Capital World Investors 16,207,905 $4.56B 2.25% 1.70% 2026-06-30
9 Bank of America Corp Custodian 14,988,328 $4.21B 2.08% 1.57% 2026-06-30
10 JPMorgan Chase & Co Custodian 12,445,411 $3.46B 1.71% 1.30% 2026-06-30
11 Northern Trust Corp Custodian 10,227,731 $2.88B 1.42% 1.07% 2026-06-30
12 Bank of New York Mellon Corp Custodian 9,269,877 $2.61B 1.29% 0.97% 2026-06-30
13 Norges Bank 8,416,339 $2.37B 1.17% 0.88% 2026-06-30
14 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Custodian 7,621,512 $2.14B 1.06% 0.80% 2026-06-30
15 FMR LLC Custodian 7,433,148 $2.09B 1.03% 0.78% 2026-06-30
16 Charles Schwab Investment Management, Inc. 7,132,137 $2.01B 0.99% 0.75% 2026-06-30
17 Goldman Sachs Group Inc Custodian 6,942,807 $1.95B 0.96% 0.73% 2026-06-30
18 Legal & General Group Plc Custodian 6,666,667 $1.87B 0.93% 0.70% 2026-06-30
19 Wellington Management Group LLP Custodian 6,549,393 $1.84B 0.91% 0.69% 2026-06-30
20 PeakShares LLC 5,897 $1.66B 0.82% <0.01% 2026-06-30
21 Dimensional Fund Advisors LP Custodian 5,584,047 $1.57B 0.78% 0.59% 2026-06-30
22 Amundi Custodian 5,462,124 $1.54B 0.76% 0.57% 2026-06-30
23 Vanguard Fiduciary Trust Co 5,277,637 $1.48B 0.73% 0.55% 2026-06-30
24 Wells Fargo & Company Custodian 5,272,282 $1.48B 0.73% 0.55% 2026-06-30
25 Ameriprise Financial, Inc. Custodian 4,787,969 $1.35B 0.67% 0.50% 2026-06-30
93 filers$6.86B notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $1.86B 27.06% 2026-06-30
2 Citadel Advisors LLC Custodian $901.17M 13.14% 2026-06-30
3 Jane Street Group, LLC Custodian $745.09M 10.86% 2026-06-30
4 IMC-Chicago, LLC Custodian $538.29M 7.85% 2026-06-30
5 Optiver Holding B.V. $446.42M 6.51% 2026-06-30
6 HSBC Holdings plc Custodian $175.39M 2.56% 2026-06-30
7 Wolverine Trading, LLC Custodian $173.67M 2.53% 2025-09-30
8 Millennium Management LLC Custodian $172.33M 2.51% 2026-06-30
9 ADAPT Investment Managers SA $161.70M 2.36% 2026-06-30
10 Barclays PLC Custodian $144.77M 2.11% 2026-06-30
11 Simplex Trading, LLC Custodian $128.46M 1.87% 2026-06-30
12 BNP Paribas Financial Markets Custodian $117.55M 1.71% 2026-06-30
13 GROUP ONE TRADING LLC Custodian $113.86M 1.66% 2026-06-30
14 Goldman Sachs Group Inc Custodian $113.75M 1.66% 2026-06-30
15 Citigroup Inc. Custodian $93.45M 1.36% 2026-06-30
16 Walleye Trading LLC $92.41M 1.35% 2026-06-30
17 National Bank of Canada Custodian $84.36M 1.23% 2026-06-30
18 PEAK6 LLC $61.33M 0.89% 2026-06-30
19 JPMorgan Chase & Co Custodian $57.32M 0.84% 2026-06-30
20 Cubist Systematic Strategies, LLC $51.35M 0.75% 2025-09-30
21 Allianz Asset Management GmbH $48.87M 0.71% 2026-06-30
22 Royal Bank of Canada Custodian $47.81M 0.70% 2026-06-30
23 Point72 Asset Management, L.P. $45.19M 0.66% 2026-06-30
24 Militia Capital Management LLC $41.51M 0.61% 2026-06-30
25 Qube Research & Technologies Ltd $37.96M 0.55% 2026-06-30
81 filers$6.28B notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $1.39B 22.13% 2026-06-30
2 Jane Street Group, LLC Custodian $824.51M 13.13% 2026-06-30
3 Citadel Advisors LLC Custodian $816.63M 13.00% 2026-06-30
4 IMC-Chicago, LLC Custodian $399.96M 6.37% 2026-06-30
5 National Bank of Canada Custodian $314.31M 5.00% 2026-06-30
6 Goldman Sachs Group Inc Custodian $296.82M 4.73% 2026-06-30
7 Millennium Management LLC Custodian $285.32M 4.54% 2026-06-30
8 Optiver Holding B.V. $212.74M 3.39% 2026-06-30
9 Citigroup Inc. Custodian $181.32M 2.89% 2026-06-30
10 ADAPT Investment Managers SA $172.24M 2.74% 2026-06-30
11 Wolverine Trading, LLC Custodian $113.46M 1.81% 2025-09-30
12 Parallax Volatility Advisers, L.P. $105.26M 1.68% 2026-06-30
13 BNP Paribas Financial Markets Custodian $94.80M 1.51% 2026-06-30
14 Simplex Trading, LLC Custodian $76.74M 1.22% 2026-06-30
15 Walleye Trading LLC $69.23M 1.10% 2026-06-30
16 Barclays PLC Custodian $63.47M 1.01% 2026-06-30
17 Allianz Asset Management GmbH $59.08M 0.94% 2026-06-30
18 JPMorgan Chase & Co Custodian $55.79M 0.89% 2026-06-30
19 UBS Group AG Custodian $49.80M 0.79% 2026-06-30
20 Balyasny Asset Management L.P. $47.19M 0.75% 2026-06-30
21 D. E. Shaw & Co., Inc. Custodian $43.93M 0.70% 2026-06-30
22 Qube Research & Technologies Ltd $42.24M 0.67% 2026-06-30
23 TUDOR INVESTMENT CORP ET AL $37.71M 0.60% 2026-06-30
24 GROUP ONE TRADING LLC Custodian $35.94M 0.57% 2026-06-30
25 PEAK6 LLC $35.77M 0.57% 2026-06-30

IBM Insider Trading (Form 4)

Latest: 2026-10-01
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-01 Martha E Pollack Director Grant (A) +268 RSU — EDGAR
2026-10-01 Frederick William McNabb III Director Grant (A) +415 RSU — EDGAR
2026-10-01 Alfred W Zollar Director Grant (A) +415 RSU — EDGAR
2026-10-01 David N Farr Director Grant (A) +268 RSU — EDGAR
2026-10-01 Andrew N Liveris Director Grant (A) +444 RSU — EDGAR
2026-10-01 Thomas Buberl Director Grant (A) +444 RSU — EDGAR
2026-10-01 Michelle J Howard Director Grant (A) +291 RSU — EDGAR
2026-10-01 Ramon Laguarta Director Grant (A) +415 RSU — EDGAR
2026-10-01 Alex Gorsky Director Grant (A) +489 RSU — EDGAR
2026-10-01 Peter R. Voser Director Grant (A) +455 RSU — EDGAR
2026-10-01 Michael Miebach Director Grant (A) +415 RSU — EDGAR
2026-10-01 Marianne Catherine Brown Director Grant (A) +415 RSU — EDGAR
2026-08-28 Arvind Krishna Chairman, President & CEO I +8,375 RSU — EDGAR
2026-08-28 Robert David Thomas Senior Vice President Sell (S) −25,000 $230.32 -$5.76M EDGAR
2026-07-02 Alfred W Zollar Director Grant (A) +325 RSU — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

IBM Insider Holdings

15 insiders · @ $253.56
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Arvind Krishna Chairman, President & CEO 474,708 $120.37M $0 62 2026-08-28
2 James J Kavanaugh Sr. VP and CFO 173,956 $44.11M -$20.75M 416 2026-02-27
3 Gary D Cohn Vice Chairman 111,031 $28.15M $0 21 2026-02-27
4 Robert David Thomas Senior Vice President 65,800 $16.68M -$12.47M 21 2026-08-28
5 Nickle Jaclyn Lamoreaux Senior Vice President 56,860 $14.42M -$774.7K 29 2026-02-27
6 Nicolas A. Fehring VP, Controller 16,577 $4.20M $0 20 2026-06-04
7 Anne Robinson Senior Vice President 13,016 $3.30M $0 8 2026-07-02
8 David N Farr Director 9,708 $2.46M $1.64M 68 2026-10-01
9 Frederick William McNabb III Director 9,676 $2.45M $999.1K 29 2026-10-01
10 Alex Gorsky Director 4,427 $1.12M $498.8K 50 2026-10-01
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

IBM Board & Officers

As of SEC filings through Oct 8, 2026

Directors 15

Officers 7

Changes in the last 10 years (29)
Oct 1, 2026Frank Baker became a director
Mar 1, 2026Ramon Laguarta became a director
Feb 25, 2025Arvind Krishna listed as Chairman, President & CEO (previously Chairman and CEO) in SEC filings
Jul 1, 2024Anne Robinson became Senior Vice President
Jan 29, 2024The company announced the departure of Thomas W Rosamilia as Senior Vice President in an SEC filing
Dec 12, 2023Robert David Thomas became Senior Vice President
Dec 12, 2023Marianne Catherine Brown became a director
Oct 30, 2023Michael Miebach became a director
Jan 30, 2023Nicolas A. Fehring became VP, Controller
Jan 31, 2022The company announced the departure of James M Whitehurst as President in an SEC filing
Oct 25, 2021Alfred W Zollar became a director
Feb 3, 2021Arvind Krishna listed as Chairman and CEO (previously CEO) in SEC filings
Jan 1, 2021Gary D Cohn became Vice Chairman
Dec 15, 2020Nickle Jaclyn Lamoreaux became Senior Vice President
Dec 15, 2020James M Whitehurst became President
May 8, 2020Virginia M Rometty listed as Executive Chairman (previously Chairman, Pres. and CEO) in SEC filings
Apr 28, 2020Thomas Buberl became a director
Apr 10, 2020Arvind Krishna listed as CEO (previously Senior Vice President) in SEC filings
Apr 10, 2020Arvind Krishna first listed as a director in an SEC filing
Oct 29, 2019Frederick William McNabb III became a director
Not reported recently (24)
  • Michelle H Browdy · Last reported as Senior Vice President in an SEC filing dated Jun 11, 2024
  • Joseph Swedish · Last reported as a director in an SEC filing dated Apr 1, 2024
  • Robert F Del Bene · Last reported as VP, Controller in an SEC filing dated Nov 22, 2022
  • Michael L Eskew · Last reported as a director in an SEC filing dated Apr 1, 2022
  • Sidney Taurel · Last reported as a director in an SEC filing dated Apr 1, 2021
  • John E Kelly III · Last reported as Executive Vice President in an SEC filing dated Dec 14, 2020
  • Virginia M Rometty · Last reported as a director in an SEC filing dated Dec 14, 2020
  • Diane J Gherson · Last reported as Senior Vice President in an SEC filing dated Nov 10, 2020
  • Kenneth M Keverian · Last reported as Senior Vice President in an SEC filing dated Jul 1, 2020
  • Martin J Schroeter · Last reported as Senior Vice President in an SEC filing dated Jun 9, 2020
  • Shirley A Jackson · Last reported as a director in an SEC filing dated Apr 1, 2020
  • James W Owens · Last reported as a director in an SEC filing dated Apr 2, 2019
  • Hutham S Olayan · Last reported as a director in an SEC filing dated Apr 2, 2019
  • Erich Clementi · Last reported as Senior Vice President in an SEC filing dated Mar 4, 2019
  • Kenneth I Chenault · Last reported as a director in an SEC filing dated Jan 2, 2019
  • W James McNerney Jr · Last reported as a director in an SEC filing dated Mar 30, 2018
  • Mark Fields · Last reported as a director in an SEC filing dated Mar 30, 2018
  • Joan E Spero · Last reported as a director in an SEC filing dated Apr 3, 2017
  • Michael D. Rhodin · Last reported as Senior Vice President in an SEC filing dated Jan 3, 2017
  • Allen Bruno V Di Leo · Last reported as Senior Vice President in an SEC filing dated Jan 3, 2017
  • Bridget A van Kralingen · Last reported as Senior Vice President in an SEC filing dated Jan 3, 2017
  • Jon C Iwata · Last reported as Senior Vice President in an SEC filing dated Nov 16, 2016
  • Robert J. LeBlanc · Last reported as Senior Vice President in an SEC filing dated Nov 9, 2016
  • Stanley J Sutula III · Last reported as VP, Controller in an SEC filing dated Nov 9, 2016
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

IBM Proposed Insider Sales (Form 144)

Latest: 2026-08-26
Last 30d: 0 filings  ·  Last 90d: 1 filing · $5.8M notice value · 1 unique filer

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: Robert Thomas (1, $5.8M)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-08-26 Robert Thomas Officer 25,000 $5.76M 2026-08-26 UBS Financial Services Inc — EDGAR
2025-03-03 ROBERT D THOMAS Officer 26,543 $6.72M 2025-03-03 Morgan Stanley Smith Barney LLC … — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-05-28
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-05-28 0000051143-26-000047 EDGAR
2026-05-01 0000051143-26-000043 EDGAR
2026-04-22 0000051143-26-000036 EDGAR
2026-03-03 0000051143-26-000015 EDGAR
2026-02-02 0001104659-26-009343 EDGAR
2026-01-30 0000051143-26-000006 EDGAR
2026-01-28 0000051143-26-000004 EDGAR
2025-10-23 0000051143-25-000063 EDGAR
2025-10-22 0000051143-25-000061 EDGAR
2025-07-24 0000051143-25-000051 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-24 0000051143-26-000010 EDGAR
2025-02-25 0000051143-25-000015 EDGAR
2024-02-26 0000051143-24-000012 EDGAR
2023-02-28 0001558370-23-002376 EDGAR
2022-02-22 0001558370-22-001584 EDGAR
2021-02-23 0001558370-21-001489 EDGAR
2020-02-25 0001558370-20-001334 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-04-23 0000051143-26-000038 EDGAR
2025-10-23 0000051143-25-000064 EDGAR
2025-07-24 0000051143-25-000052 EDGAR
2025-04-24 0000051143-25-000032 EDGAR
2024-10-30 0000051143-24-000049 EDGAR
2024-07-30 0000051143-24-000039 EDGAR
2024-04-30 0000051143-24-000025 EDGAR
2023-10-31 0000051143-23-000032 EDGAR
2023-07-25 0000051143-23-000021 EDGAR
2023-04-25 0001558370-23-006656 EDGAR
ETF Holders
433 ETFs hold IBM
25 shown · $31.75B total exposure · 0.54% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.28% $6.6B — 2026-09-30
2 VOO Vanguard S&P 500 ETF Vanguard 0.31% $5.4B — 2026-09-30
3 IVV iShares Core S&P 500 ETF iShares (BlackRock) 0.36% $3.2B $873.6B 2026-10-22
4 SPY State Street® SPDR® S&P 500® ETF Trust SPDR (State Street) 0.36% $2.9B $810.5B 2026-10-22
5 VTV Vanguard Morningstar Value ETF Vanguard 0.79% $2.0B — 2026-09-30
6 XLK State Street® Technology Select Sector SPDR® ETF SPDR (State Street) 1.44% $1.7B $120.1B 2026-10-22
7 VGT Vanguard Information Technology ETF Vanguard 0.77% $1.4B — 2026-09-30
8 DIA State Street® SPDR® Dow Jones Industrial Average® ETF Trust SPDR (State Street) 2.83% $1.3B $45.7B 2026-10-22
9 VIG Vanguard Dividend Appreciation ETF Vanguard 0.92% $1.2B — 2026-09-30
10 VYM Vanguard High Dividend Yield ETF Vanguard 0.88% $841.7M — 2026-09-30
11 DGRO iShares Core Dividend Growth ETF iShares (BlackRock) 1.50% $670.8M $44.5B 2026-10-22
12 SPYM State Street® SPDR® Portfolio S&P 500® ETF SPDR (State Street) 0.36% $656.0M $182.5B 2026-10-22
13 IWD iShares Russell 1000 Value ETF iShares (BlackRock) 0.63% $532.0M $84.5B 2026-10-22
14 TDIV First Trust NASDAQ Technology Dividend Index Fund First Trust 8.80% $380.6M $4.3B 2026-10-23
15 CIBR First Trust Nasdaq Cybersecurity ETF First Trust 2.04% $374.8M $18.4B 2026-10-23
16 ITOT iShares Core S&P Total U.S. Stock Market ETF iShares (BlackRock) 0.32% $308.5M $95.8B 2026-10-22
17 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.34% $296.5M — 2026-10-22
18 SCHX Schwab U.S. Large-Cap ETF Nport 0.41% $295.8M — 2026-05-31
19 IYW iShares U.S. Technology ETF iShares (BlackRock) 1.21% $292.3M $24.3B 2026-10-22
20 SDY State Street® SPDR® S&P® Dividend ETF SPDR (State Street) 1.23% $273.5M $22.2B 2026-10-22
21 DGRW WisdomTree U.S. Quality Dividend Growth Fund Nport 1.59% $263.8M — 2026-06-30
22 IVW iShares S&P 500 Growth ETF iShares (BlackRock) 0.35% $263.0M $75.4B 2026-10-22
23 VV Vanguard Morningstar Large-Cap ETF Vanguard 0.32% $244.1M — 2026-09-30
24 DVY iShares Select Dividend ETF iShares (BlackRock) 0.88% $208.6M $23.5B 2026-10-22
25 RSP Invesco S&P 500 Equal Weight ETF Invesco 0.21% $207.5M — 2026-10-24
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
21.78
TTM Diluted EPS
$11.64
TTM Revenue
$69.87B
TTM Net Income
$11.17B
TTM Op. Cash Flow
$15.83B
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q3 '262026-09-30$17.10B$2.19B$2.30$4.03B
Q2 '262026-06-30$17.16B$2.17B$2.27$2.60B
Q1 '262026-03-31$15.92B$1.22B$1.30$5.17B
Q4 '252025-12-31$19.68B$5.60B$5.81$4.04B
Q3 '252025-09-30$16.33B$1.74B$1.84$3.08B
Q2 '252025-06-30$16.98B$2.19B$2.31$1.70B
Q1 '252025-03-31$14.54B$1.05B$1.14$4.37B
Q4 '242024-12-31$17.55B$2.91B$3.05$4.33B
Q3 '242024-09-30$14.97B$-330.00M$-0.36$2.88B
Q2 '242024-06-30$15.77B$1.83B$1.96$2.06B
Q1 '242024-03-31$14.46B$1.60B$1.72$4.17B
Q4 '232023-12-31$17.38B$3.29B$3.56$4.46B
Q3 2026 • period ending 2026-09-30 • filed 2026-10-22
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
22.54
P/B
6.93
P/S
3.46
EV/EBITDA
16.41
EV/Sales
4.17
ROE
31.1%
ROA
7.1%
Div Yield
2.66%
FCF Yield
6.22%
Debt/Equity
1.63
Current Ratio
—
Market Cap
$239.26B
as of 2026-10-23
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
24.16M
SI % of Float
2.75%
Days to Cover
4.09
Short Vol Ratio
44.5%
Free Float
879.86M
Float %
93.4%
Short interest 2026-09-30 • Short volume 2026-10-23 • Float 2026-09-23